BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34384539)

  • 1. Towards a European strategy to address the COVID-19 pandemic.
    Priesemann V; Balling R; Bauer S; Beutels P; Valdez AC; Cuschieri S; Czypionka T; Dumpis U; Glaab E; Grill E; Hotulainen P; Iftekhar EN; Krutzinna J; Lionis C; Machado H; Martins C; McKee M; Pavlakis GN; Perc M; Petelos E; Pickersgill M; Prainsack B; Rocklöv J; Schernhammer E; Szczurek E; Tsiodras S; Van Gucht S; Willeit P
    Lancet; 2021 Sep; 398(10303):838-839. PubMed ID: 34384539
    [No Abstract]   [Full Text] [Related]  

  • 2. To curb COVID-19, global health must go local.
    Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 4. Venezuela is collapsing without COVID-19 vaccines.
    Loyo ESL; González MJ; Esparza J
    Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
    [No Abstract]   [Full Text] [Related]  

  • 5. The long road ahead for COVID-19 vaccination in Africa.
    Jerving S
    Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
    [No Abstract]   [Full Text] [Related]  

  • 6. What constitutes success in the roll-out of COVID-19 vaccines?
    Smith MJ
    Lancet; 2021 Jul; 398(10295):115-116. PubMed ID: 34181882
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 - Inequities, the third wave and vaccination.
    Govender I
    S Afr Fam Pract (2004); 2021 Aug; 63(1):e1-e2. PubMed ID: 34476960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines for children in LMICs: another equity issue.
    Kampmann B; Okomo U
    Lancet; 2021 Aug; 398(10302):731-732. PubMed ID: 34339625
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Karafillakis E; Van Damme P; Hendrickx G; Larson HJ
    Lancet; 2022 Feb; 399(10326):699-701. PubMed ID: 35123665
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting refugees during the COVID-19 pandemic.
    The Lancet
    Lancet; 2021 Jun; 397(10292):2309. PubMed ID: 34147144
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.
    Baker MG; Wilson N; Blakely T
    BMJ; 2020 Dec; 371():m4907. PubMed ID: 33561814
    [No Abstract]   [Full Text] [Related]  

  • 16. Tanzania's position on the COVID-19 pandemic.
    Mfinanga SG; Mnyambwa NP; Minja DT; Ntinginya NE; Ngadaya E; Makani J; Makubi AN
    Lancet; 2021 Apr; 397(10284):1542-1543. PubMed ID: 33864748
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence and Precaution for Legal Health Interventions: Learning From the COVID-19 Pandemic.
    Bretthauer M; Helsingen LM; Løberg M; Kalager M; Guyatt G
    Ann Intern Med; 2021 Oct; 174(10):1456-1457. PubMed ID: 34370512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic.
    Jung AS; Haldane V; Neill R; Wu S; Jamieson M; Verma M; Tan M; De Foo C; Abdalla SM; Shrestha P; Chua AQ; Bristol N; Singh S; Bartos M; Mabuchi S; Bonk M; McNab C; Werner GK; Panjabi R; Nordström A; Legido-Quigley H
    BMJ; 2021 Nov; 375():e068954. PubMed ID: 34840138
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 in Turkey: a nation on edge.
    Genç K
    Lancet; 2021 May; 397(10287):1794-1796. PubMed ID: 33992132
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there light at the end of the Covid-19 tunnel?
    Mortimer PP
    Rev Med Virol; 2021 May; 31(3):e2173. PubMed ID: 33002254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.